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Abstract
Background: Advances in diagnostic and therapeutic modalities for congenital cytomegalovirus (CMV) infection
have generated a mounting interest in identifying mothers susceptible to CMV. The objectives of this study were
to evaluate the prevalence and socio-demographic determinants of CMV susceptibility and CMV awareness, among
pregnant women, in Montreal, Quebec.
Methods: Between April and December 2012, women delivering at Centre Hospitalier Universitaire Sainte Justine
were recruited for the study. Stored serum from the first trimester of pregnancy was tested for CMV IgG. Knowledge
about CMV and socio-demographic characteristics were collected via standardized questionnaire.
Results: Four hundred and ninety one women were enrolled in the study. Overall, 225 mothers (46 %) were
seronegative for CMV, and 85 % (n = 415) were unaware of CMV or the associated risks in pregnancy. Significant risk
factors for CMV seronegative status included Canadian vs. foreign born (aOR 6.88, 95 % CI 4.33–10.94), and high vs. low
family income (aOR 4.68, 95 % CI 2.09–10.48). Maternal employment status was the only significant predictor of CMV
unawareness, with unemployed mothers at the highest risk (aOR 85.6, 95 % CI 17.3–421.3).
Conclusions: Nearly half of pregnant women studied were at risk of primary infection, and yet, the majority was
unaware of potential risks associated with CMV. Canadian born mothers and those with a high socioeconomic status
were more likely to be CMV seronegative. Increased education about CMV infection, through public health
interventions and obstetrician/pediatric counseling, is needed for all pregnant women.
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Background
Cytomegalovirus (CMV) is the most common cause of
congenital infection, with an overall birth prevalence in
the developed world of 0.64 % [1]. Congenital CMV infec-
tion (cCMV) is the leading non-genetic cause of deafness
in children [2] and is also responsible for significant devel-
opmental delays in infected children, whether symptom-
atic or not at birth [3]. Overall ensuing societal costs are
estimated to be billions of dollars annually [4, 5], with at
least $14.3 million per year for the hospitalization of
symptomatic infants in the United States [6].
Primary maternal CMV infection during pregnancy
will result in viral transmission to the fetus in 40 % of
cases, whereas 1 % of women already infected before
pregnancy (known CMV seropositive) will transmit the
virus, either through viral reactivation or reinfection
with a different strain [7]. However, the severity of fetal
complications is highest with maternal primary infection
early in pregnancy [8, 9]. Therefore, maternal CMV
seronegative status constitutes a major risk factor for
congenital CMV disease in children.
Although the role of screening for CMV has been in-
tensely debated in the last decade [10, 11], there remains
no consensus on the need to screen all pregnant women,
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nor on selected populations to target. Recent advances
in both diagnostic and therapeutic modalities in man-
aging congenital CMV have also ignited interest in the
need for neonatal screening [12–17]. While early treat-
ment may well limit the sequelae of disease in children,
prevention remains the cornerstone of efforts to limit
the global burden of cCMV disease [18]. Until an effect-
ive CMV vaccine becomes available, behavioral interven-
tions may indeed represent the best preventive measure
for cCMV. Education on basic hygiene measures to
newly pregnant at risk mothers proved to significantly
reduce the incidence of maternal infection during preg-
nancy [19–21]. However, in Canada, there is limited data
on which women are actually at risk for primary CMV
infection. The first Canadian epidemiologic studies in
the 1970s revealed a maternal seronegative status rate of
56–64 % [22–26]. More recent data in selected sub-
groups showed a lower rate of 43 % in daycare workers
in Montreal [27] and of 45 % in mothers of low birth
weight infants in Alberta [28]. Given that socio-
demographic factors have greatly changed overtime in
Canada, with successive immigration waves, smaller
family sizes and new child daycare programs, current
data on CMV risk in pregnancy are essential to iden-
tify targeted groups for public health interventions.
The primary objective of this study was to determine
CMV susceptibility and awareness of CMV disease
among pregnant women delivering at Centre Hospita-
lier Universitaire (CHU) Sainte-Justine, in Montreal,
Quebec. Secondary objectives were to determine risk




All pregnant women delivering at CHU Sainte-Justine
between April and December 2012 were eligible for the
study. There are approximately 3500 live births annually
at this tertiary care mother-child hospital, which repre-
sent 15 % of births in the city of Montreal, which itself
represents more than a quarter of births of the Province
of Quebec [29]. The cost of medical care for all women
is provided by the provincial health plan, under a system
of universal health care access.
Inclusion criteria for the study were: 1) Availability of
stored first trimester blood in the Sainte-Justine labora-
tory 2) Age older than 18 years and 3) Capacity to pro-
vide written consent in French or English. Mothers
whose babies were hospitalized in the neonatal intensive
care unit were excluded from the study to prevent add-
itional hospitalization stress. Recruitment occurred on
the postpartum ward on 80 pre-specified weekdays,
based on staffing availability. Members of the research
team (SW and LC) and a research assistant approached
mothers before their hospital discharge. During the same
interview, they obtained patient consent to participate in
the study, administered and simultaneously completed
the standard questionnaire described below.
The ethics committee of the Sainte-Justine research
center approved the study.
Serology
Maternal CMV IgG antibody levels were measured on
stored first trimester routine blood test using the auto-
mated enzyme immunoassay analyzer Triturus (Diagnos-
tics Grifols, S.A., Barcelona, Spain). CMV serostatus was
defined as negative if a serum titer was < 0.9 U/mL,
equivocal between 0.9 and 1.1 U/mL, and positive if >1.1
U/mL. Laboratory results were mailed to the mothers
along with an explanatory letter. A pamphlet about pre-
ventive measures on CMV transmission was added for
seronegative mothers in order to educate them about
CMV prevention for subsequent pregnancies.
Sociodemographic data collection
During the postpartum interview, women were adminis-
tered a 10-item standardized questionnaire including:
knowledge about CMV, knowledge of their CMV status,
age, birthplace, age at immigration if foreign born, edu-
cation level, family revenue, number of children, age of
children, number of children who attended daycare, and
employment type (See Additional file 1 for full question-
naire). CMV awareness was categorized as CMV aware if
women reported awareness by answering yes to either of
the following questions: 1) Do you know anything about
cytomegalovirus? and 2) Do you know if you are pro-
tected against cytomegalovirus? Age was classified into
three groups (18–30, 31–35, ≥36 years old). Place of
birth of mothers were classified as: Canada, United
States of America, Caribbean, South America, Europe,
Africa, and Asia. Age at immigration was divided into
two groups: younger than 12 years old or older [30]. The
three categories for family income (≤$30,000, $31–
99,000, and ≥ $100, 000) were based on Statistics Canada
classifications [31]. Level of education was categorized
into two groups of pre-university and university levels.
Occupational exposure was specified as working in child
daycare centers, or working in health care facilities, such
as hospitals, medical clinics, and long term care institu-
tions, regardless of credentials.
Statistical analysis
The association between maternal socio-demographic
characteristics and CMV seronegative status and CMV
awareness were assessed using odds ratios. Multivariable
logistic regression was used to adjust for potential con-
founders identified on univariate analysis and from the
literature, including maternal age, birth place, education
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level, income, number of children, and type of employ-
ment. The multivariable analysis was restricted to only
those women with complete data on all variables
assessed (n = 479). All statistical tests were two-sided,
and significance was set at a p < 0.05. The analysis was
conducted using SAS statistical software, version 9.3
(SAS institute, Cary, NC).
Results
Between April and December 2012 (240 days), 2659
women delivered in the maternity ward of CHU Sainte
Justine. Recruitment took place for 80 days during that
period. Detailed census of delivered women was collected
for a third (27 days between October and December 2012)
of the study period, during which time 439 women deliv-
ered. Of these women, 314 women were eligible for the
study (85 women were excluded as they did not have first
trimester serum available, 35 had babies hospitalized in
the neonatal intensive care unit, two were minors and
three had linguistic barriers). One hundred and fifty-seven
(50 %) of these eligible women were not approached for
recruitment due to logistic reasons (women not available
due to medical interventions, away from the room, busy
with other healthcare worker). Of the 157 women
approached, nine (5.7 %) refused to participate in the
study, resulting in 148 recruited women during the 27-day
period. In summary, during the entire 240-day study
period, 505 women were successfully recruited over 80
recruitment days. Fourteen of the recruited women were
excluded from the final analysis (2 blood samples had in-
sufficient quantity for testing, three laboratory requests
were non-conforming, and nine laboratory results were
equivocal), leaving 491 study subjects. All of the recruited
women completed the questionnaire.
Overall, 46 % (n = 225) of women were CMV seronega-
tive. The risk of being CMV seronegative according to ma-
ternal socio-demographic characteristics is summarized in
Table 1. In the unadjusted analysis, significant risk factors
for CMV seronegative status included Canadian vs. foreign
born women (OR 8.28, 95 % CI 5.45–12.58), high or mid-
dle vs. low income (OR 8.13, 95 % CI 4.46–14.85, OR
3.68, 95 % CI 2.10–6.47, respectively), having no children
or one other child vs. two children or more (OR 2.08,
95 % CI 1.25–3.47 and OR 2.02, 95 % CI 1.18–3.44, re-
spectively). Compared to those women who did not work
outside the home, health care workers had a significantly
increased risk of CMV seronegative status (OR 3.35, 95 %
CI 1.70–6.62) as did all other trades (OR 2.10, 95 % CI
1.33–3.32), with the exception of daycare workers (OR
1.73, 95 % CI 0.71–4.19). There was no significant effect
of age on CMV serostatus. In the multivariate analysis, the
only significant risk factors for seronegative status
remained Canadian vs. foreign-born women (aOR 6.88,
95 % CI 4.33–10.94), and high or middle vs. low family
income (aOR 4.68, 95 % CI 2.09–10.48 and aOR 3.05,
95 % CI 1.54–6.04, respectively). Among foreign-born
women, 41 % were from Africa, 27 % from South America
or the Caribbean, 24 % from Europe or the United States,
and 8 % from Asia. The highest proportion of CMV sero-
negative foreign-born women was from Europe and the
United States (58 %), while the lowest proportion was
from Asia (12 %) (Fig. 1). Young age at immigration
(≤12 years old) was significantly associated with seronega-
tive status (aOR 4.23, 95%CI 1.28–13.96).
The association between maternal CMV awareness, and
CMV serostatus and socio-demographic factors is summa-
rized in Table 2. Overall, 85 % of women (n = 415)
were not aware of CMV infection. Among them, 42.4 %
(n = 176) were CMV susceptible. Significant risk factors
for being CMV unaware included foreign vs. Canadian
born women (OR 2.06, 95 % CI 1.22–3.49), non-university
vs. university educated (OR 2.43, 95 % CI 1.37–4.32),
low or middle vs. high income family (OR 5.18, 95 %
CI 2.10–12.81 and OR 2.01, 95 % CI 1.18–3.40, re-
spectively), and unemployment or employment in the
daycare setting or others trades vs. in the health care
setting (OR 64.9, 95 % CI 18.1–232.9, OR 20.6 95 %
CI 4.3–96.9 and OR 12.7, 95 % CI 6.6–24.6, respect-
ively). There was no significant effect of age or having
children on CMV awareness. In the multivariate analysis
however, only employment status remained a significant
predictor of CMV unawareness (aOR 85.6, 95 % CI 17.3–
421.3, aOR 18.6, 95 % CI 3.6–95.9 and aOR 16.1, 95 % CI
7.9–33.9, for unemployed, daycare workers, and other
trades, respectively).
Discussion
In this single center observational study from the cosmo-
politan city of Montreal, Quebec, we identified a number
of risk factors for CMV seronegative status and lack of
CMV awareness among post-partum women. While over-
all CMV susceptibility among pregnant women from the
same hospital has decreased from a reported 63.3 % [25]
in 1972 to 46 % in the present study, Canadian born
women continue to be at increased risk of CMV seronega-
tive status when compared to foreign born. In that previ-
ous study, 73 % of Canadian mothers were seronegative
vs. 29 % of Italian mothers, which is comparable to the
current 66 % susceptibility rate in Canadian born vs. 20 %
in foreign mothers in the present study. The overall de-
crease in the number of CMV seronegative pregnant
women is likely related to the smaller proportion of
Canadian born women, due to migratory trends in the
province of Quebec since the end of the 1970s [29]. Family
income was identified as another factor for CMV sero-
negative status, with women of higher family income at
increased risk of CMV seronegative status. These findings
were also compatible with the recent Australian study that
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highlighted a marked socioeconomic gradient in CMV
seroprevalence and its positive association with congenital
CMV [32]. Our overall proportion of CMV seronegative
pregnant women is similar to that reported in other
wealthy countries such as Australia (43 %), France (48 %),
and United States (28–49 %) [32].
Table 1 Maternal CMV serostatus according to socio-demographic characteristics:
Population CMV negative CMV positive Crude OR (95 % CI) p-value Adjusted OR† (95 % CI) p-value
N (column %) N (row %) N (row %) N = 479
491 (100) 225 (46) 266 (54)
Age group
18–30 185 (38) 83 (45) 102 (55) 1.00 0.95
(0.63–1.58) 0.98 (0.51–1.76) 0.87
31–35 186 (38) 88 (47) 98 (53) 1.10(0.69–1.74) 0.69 0.69(0.39–1.23) 0.21
≥ 36 120 (24) 54 (45) 66 (55) 1 1
Born in Canada
Yes 272 (55) 182 (67) 90 (33) 8.28 6.88
(5.45–12.58) <0.0001 (4.33–10.94) <0.0001
No 219 (45) 43 (20) 176 (80) 1 1
Education level
Up to university 188 (38) 76 (40) 112 (60) 1 1
University 303 (62) 149 (49) 154 (51) 1.43 0.06 1.01 0.96
(0.99–2.06) (0.60–1.70)
Family incomea (N = 479)
Low 101 (21) 19 (19) 82 (81) 1 1
Middle class 228 (48) 105 (46) 123 (54) 3.68 <0.0001 3.05 0.002
(2.10–6.47) (1.54–6.04)
High 150 (31) 98 (65) 52 (35) 8.13 <0.0001 4.68 0.0002
(4.46–14.85) (2.09–10.48)
Other children
0 229 (47) 113 (49) 116 (51) 2.08 0.01 1.59 0.30
(1.25–3.47) (0.66–3.86)
1 171 (35) 83 (49) 88 (51) 2.02 0.005 1.54 0.19
(1.18–3.44) (0.81–2.93)
≥ 2 91 (18) 29 (32) 62 (68) 1 1
Daycare
Yes 218 (44) 93 (43) 125 (57) 1 1
No 273 (56) 132 (48) 141 (52) 1.26 0.21 1.14 0.74
(0.88–1.80) (0.51–2.54)
Employment
None 112 (23) 35 (31) 77 (69) 1 1
DCW 25 (5) 11 (44) 14 (56) 1.73 1.81
(0.71–4.19) 0.23 (0.60–5.50) 0.29
HCW 53 (11) 32 (60) 21 (40) 3.35 1.19
(1.70–6.62) 0.0005 (0.47–3.03) 0.71
Others 301 (61) 147 (49) 154 (51) 2.10 0.92
(1.33–3.32) 0.002 (0.51–1.66) 0.78
alow = ≤ 30,000 $/y, middle = 31–99,000 $/y, high = ≥ 100, 000$/y
† OR adjusted for all variables in the table
DCW daycare worker, HCW health care worker
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In contrast with previous studies [33, 34], risk factors
that were not significant for seronegative status in the
present study included age, level of education, number of
children, and attendance at daycare. While this may in
part be due to our relatively small sample size, we suspect
that socio-demographic trends unique to Canada, and
specifically to the province of Quebec, may provide fur-
ther explanation.
Education level was not predictive of CMV susceptibil-
ity potentially because our population was highly edu-
cated (61 % had a university degree) independently of
the country of birth. In fact, Canada has the highest pro-
portion (64.1 %) of adult population with post-secondary
education among developed countries and the propor-
tion of recent immigrants with a university degree is
twice as high as among Canadian born fellows [35].
Family size and subsidized day care centers pro-
grams are also recent changes that might have influ-
enced the epidemiology of CMV in the province of
Quebec. Family size in Canada decreased from 3.7 in
1971 to 2.5, and even to 2.3 persons in Quebec, in
2011 [36]. With an increase in the number of subsi-
dized child daycare programs across Canada, childcare
spaces doubled from 1992 to 2004, of which 43 % were
in Quebec (although this province represents only
22 % of the Canadian population) [36]. Among the
262 studied women who had children previously, 83 %
had children with day care exposure. These two risk
factors were therefore too correlated to measure the
independent effects from children exposure at home
and their daycare attendance on maternal seronegative
status.
Finally, we did not see an increased risk of seronega-
tive status among daycare workers. While they were only
25 mothers in that category, their seronegativity rate was
comparable to that of the whole cohort. This is similar
to the result of a previous study of daycare workers in
Montreal, where 43 % were seronegative, although 69 %
were Canadian born [27]. Daycare workers in Toronto
had a lower seronegativity rate (33 %) but those sero-
negative workers experienced a high rate of seroconver-
sion (12.5 % in 1 year) [37].
Perhaps most concerning is that while 46 % of
mothers studied were seronegative and thus susceptible
to primary infection during pregnancy, only 15 % of
mothers (and 22 % of the seronegative ones) were aware
of CMV. Even among healthcare workers, only 64 %
were aware of CMV in our study. This level of awareness
about CMV was similar to the 14–25 % rate reported in
United States [38, 39], and the 12.5 % among Dutch
pregnant women [40]. Interestingly, although CMV is
the most common congenital infection, Dutch mothers
seemed much more aware of other congenital infections
like toxoplasmosis and listeriosis. Identifying women
with a lack of CMV awareness is important so as to
target appropriate public health interventions. Lack of
knowledge may lead to more risky behaviors and increase
risks of infection. It has been well demonstrated that sero-
negative mothers with a child less than 36 months of age
attending daycare who already knew that they were
Fig. 1 CMV serostatus according to place of birth
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pregnant were more motivated to alter behavior than
mothers attempting pregnancy. In that study, counseling
pregnant women was 85 % effective in reducing risk of
CMV acquisition [41]. Indeed, according to the 2002
statement of the American College of Obstetrics and
Gynecology, the greatest impact to reduce CMV diseases
is educating pregnant women about preventive measures
[42]. Yet, less than half of US obstetricians had mentioned
them to their patients in the 2008 National Survey [43].
Other than health care workers, most of our participants
were unaware about CMV, even those working in high-
risk setting such as the daycare. Given the few CMV aware
women, our sample size may have been too small to dis-
cern that influence.
The limitations of the present study are that it was a
single center study, which may not be representative of
the larger Canadian population. While the proportion of
foreign-born mothers in our population was representa-
tive of the metropolitan Montreal population [29] it does
not reflect the rest of the province of Quebec, which has
lower immigrant populations [44], or Western Canada,
which counts immigrants mostly from Asia and India.
Table 2 Maternal CMV awareness according to socio-demographic characteristics






N (column %) N (row %) N (row %) N = 479
491 (100) 76 (15) 415 (85)
CMV status
CMV negative 225 (46) 49 (22) 176 (78)
CMV positive 266 (54) 27 (10) 239 (90)
Age group
18–30 185 (38) 18 (10) 167 (90) 1.64 (0.81–3.29) 0.17 1.79 (0.74–4.32) 0.20
31–35 186 (38) 40 (22) 146 (78) 0.64 (0.35–1.19) 0.16 0.81 (0.39–1.69) 0.58
≥ 36 120 (24) 18 (15) 102 (85) 1 1
Born in Canada
Yes 272 (55) 53 (19) 219 (81) 1 1
No 219 (45) 23 (11) 196 (89) 2.06 (1.22–3.49) <0.01 1.81 (0.92–3.55) 0.08
Education level
Up to university 188 (38) 17 (9) 171 (91) 2.43 (1.37–4.32) <0.003 1.40 (0.66–2.97) 0.38
University 303 (62) 59 (19) 244 (81) 1 1
Family incomea (N = 479)
Low 101 (21) 6 (6) 95 (94) 5.18 (2.10–12.81) <0.001 0.89 (0.28–2.86) 0.84
Middle class 228 (48) 32 (14) 196 (86) 2.01 (1.18–3.40) <0.01 1.02 (0.52–2.04) 0.95
High 150 (31) 37 (25) 113 (75) 1 1
Other children
0 229 (47) 35 (15) 194 (85) 1 1
1 171 (35) 32 (19) 139 (81) 0.78 (0.46–1.33) 0.36 0.88 (0.27–2.88) 0.93
≥ 2 91 (18) 9 (10) 82 (90) 1.64 (0.76–3.57) 0.21 2.67 (0.63–11.41) 0.18
Daycare
Yes 218 (44) 35 (16) 183 (84) 1 1
No 273 (56) 41 (15) 232 (85) 1.08 (0.66–1.77) 0.75 0.84 (0.26–2.75) 0.77
Employment
None 112 (23) 3 (3) 109 (97) 64.9 (18.1–232.9) <0.0001 85.6 (17.3–421.3) <0.0001
Others 301 (61) 37 (12) 264 (88) 12.7 (6.6–24.6) <0.0001 16.1 (7.6–33.9) <0.0001
DCW 25 (5) 2 (8) 23 (92) 20.6 (4.3–96.9) 0.0001 18.6 (3.6–95.9) 0.0005
HCW 53 (11) 34 (64) 19 (36) 1 1
alow = ≤ 30,000 $/y, middle = 31–99,000 $/y, high = ≥ 100, 000$/y
† OR adjusted for all variables in the table except CMV status
DCW daycare worker, HCW health care worker
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Moreover, CHU Sainte-Justine is a francophone referral
hospital, and thus mothers from the First Nations and
the Asian continent (more likely to be English speaking)
are likely underrepresented. Furthermore, the level of
wealth of participants in our study is higher than that
described in the general population of Canada, which
may make it difficult to generalize our results. Finally,
our sample size may have been too small to detect dif-
ferences in the socio-demographic risk factors for CMV
seronegative status and awareness, given the large num-
ber of explanatory variables per category. Larger, more
representative population level studies are needed to
identify more precisely these risk factors and target
groups for anticipatory behavioral intervention.
Conclusions
In conclusion, in the present study, we identified a high
proportion of CMV seronegative status and unawareness
among pregnant women. Given that there is no current
consensus on the role of CMV screening of pregnant
women, primary prevention through education of at risk
women about CMV transmission and basic hygiene pre-
ventive measures could potentially have a major public
health impact. Moreover, increased education of health
care workers, who themselves may lack CMV awareness,
could help reinforce these education measures. In this
respect, collaboration with other large mother-child cen-
ters in the province of Quebec and other provinces
across Canada are needed to improve the reproducibility
and generalizability of our findings and to develop public
health interventions.
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